Ozon Pharmaceuticals Group completed the installation of industrial equipment on the production line for active pharmaceutical substances in Togliati. Installation of three 2000-liter bioreactors and chromatographs was completed. New lines will allow to produce up to 1 million vials of lyophilizates, 5 million prefilled syringes and more than 4 million vials of sterile solutions annually. Total investment in the project amounted to ₽0.8 billion. Sales of the first biotech drugs are scheduled to start in 2027.